Savara Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Savara Inc (SVRA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 12.23 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 12.23M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 12.87M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 13.24M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 13.21M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 12.23M shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 12.87M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 13.24M shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 13.21M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 13.19M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 13.09M shares 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 13.55M shares 10-K · filed 2026-03-13 | |
| 2024-09-30 | 9.48M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 9.74M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 9.79M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 9.63M shares 10-K · filed 2025-03-27 | |
| 2023-09-30 | 8.55M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 8.53M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 8.44M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 7.93M shares 10-K · filed 2024-03-07 | |
| 2022-09-30 | 5.85M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 6.06M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 6.20M shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | 6.22M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 4.98M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 5.13M shares 10-Q · filed 2021-08-12 | |
| 2020-12-31 | 6.24M shares 10-K · filed 2022-03-30 | |
| 2020-09-30 | 4.69M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 4.40M shares 10-Q · filed 2021-08-12 | |
| 2019-12-31 | 4.54M shares 10-Q · filed 2021-11-12 | |
| 2018-12-31 | 3.08M shares 10-K · filed 2019-03-13 | |
| 2017-12-31 | 1.92M shares 10-K · filed 2018-03-14 | |
| 2017-03-31 | 285.82K shares 10-Q · filed 2017-05-09 | |
| 2016-12-31 | 315.20K shares 10-Q · filed 2017-05-09 | 22.07M shares 10-K · filed 2017-03-06 |
| 2016-09-30 | 29.90M shares 10-Q · filed 2016-11-08 | |
| 2016-06-30 | 30.04M shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 30.20M shares 10-Q · filed 2016-05-06 | |
| 2015-12-31 | 22.90M shares 10-K · filed 2017-03-06 | |
| 2015-09-30 | 22.46M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 22.46M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 19.36M shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 13.62M shares 10-K · filed 2016-03-14 | |
| 2014-09-30 | 13.06M shares 10-Q · filed 2014-10-31 | |
| 2014-06-30 | 14.15M shares 10-Q · filed 2014-08-11 | |
| 2014-03-31 | 9.49M shares 10-Q · filed 2014-05-05 | |
| 2013-12-31 | 7.30M shares 10-K · filed 2015-03-24 | |
| 2013-09-30 | 7.15M shares 10-Q · filed 2013-11-04 | |
| 2012-12-31 | 3.59M shares 10-K · filed 2014-03-26 | |
| 2011-12-31 | 2.89M shares 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |